October 27, 2026

Mayo Clinic: Cerebrospinal fluid liquid biopsy detects tumor DNA in complex brain cases

A Mayo Clinic study published in the Journal of Neuro-Oncology suggests that analyzing DNA in cerebrospinal fluid could provide another source of information when MRI cannot provide a clear brain tumor diagnosis or obtaining tissue through biopsy is difficult or...

recent articles

VISTA, California, ALBUQUERQUE, New Mexico, and SEOUL, South Korea — May 26, 2026 — Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Indica Labs, a global leader in...

Pictor Labs, the UCLA spinout behind a suite of AI-powered virtual staining tools, used USCAP 2026, the annual pathology meeting in Los Angeles, to debut a dedicated on-premises hardware system that runs its full product line, including...

ROCHESTER, Minn. — Mayo Clinic Digital Pathology (MCDP) is advancing efforts to build an integrated innovation ecosystem that supports the future of pathology across clinical care and research. The work reflects Mayo Clinic’s broader...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic test will...

Grundium Acquires Visiopharm: The combined platform brings together digital slide scanning and AI-driven precision pathology software to accelerate accessible and scalable adoption of precision diagnostics TAMPERE, FI AND COPENHAGEN, DK...

Taylor & Francis is pleased to invite you to submit your work to an upcoming Article Collection on “Breast cancer biomarkers in diagnostic and translational pathology” in the journal Breast Cancer: Targets and Therapy. This Article...

OR

platinum partners

gold partners

Silver Partners

Media Partners